Latest News
President-elect Donald Trump and the head of Japanese tech conglomerate SoftBank, Masayoshi Son, will announce a $100 billion investment effort designed to spur artificial...
Hi, what are you looking for?
The former head of Ozy Media has been sentenced to 10 years in prison for his role in an alleged fraud involving the failed...
President-elect Donald Trump and the head of Japanese tech conglomerate SoftBank, Masayoshi Son, will announce a $100 billion investment effort designed to spur artificial...
A rocky year for restaurants separated the industry’s biggest chains into winners and losers, as eateries competed for a smaller pool of customers who...
By Nicole Jao NEW YORK (Reuters) – Fuelmakers in California could face more headwinds next year as new legislation takes effect and refining margins...
By Stephen Nellis SANTA BARBARA, California (Reuters) – Google on Monday said that it has overcome a key challenge in quantum computing with a...
After-Hours Stock Movers: Oracle (NYSE:ORCL) fell 6% after second quarter results missed estimates on the top and bottom line. Q2 Cloud Infrastructure (IaaS) revenue...
Investing.com — C3.ai on Monday raised its full-year revenue guidance following fiscal second-quarter results that topped Wall Street estimates., C3.ai Inc (NYSE:AI) climbed more...
(Reuters) -Oracle missed Wall Street expectations for second-quarter revenue and adjusted profit on Monday, hit by stiff competition and softer-than expected spending on its...
TikTok in a court filing Monday warned that U.S. small businesses and social media creators would lose $1.3 billion in revenue and earnings in just...
By Ismail Shakil OTTAWA (Reuters) – The Canadian government will present its fall economic statement on Dec. 16, the finance ministry said on Monday,...
Investing.com — The Federal Reserve is likely to cut rates next week, but a slew of data pointing to a still strong labor market...
(Reuters) – Citigroup (NYSE:C), previously the only Wall Street brokerage forecasting a 50 basis point rate cut by the U.S. Federal Reserve, has now...
(Reuters) -Crown Laboratories would buy the anti-wrinkle injection maker Revance Therapeutics (NASDAQ:RVNC) at a roughly 50% lower price compared to an original agreement signed...